Skip to main navigation
Skip to search
Skip to main content
University College Cork Home
Search content at University College Cork
Home
Profiles
Research units
Research output
Activities
Prizes
Datasets
Impacts
Courses
Press/Media
Mesalazine in inflammatory bowel disease: A trendy topic once again?
Marietta Iacucci
, Shanika De Silva
,
Subrata Ghosh
Imperial College Healthcare NHS Trust
University of Calgary
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Mesalazine in inflammatory bowel disease: A trendy topic once again?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Inflammatory Bowel Disease
100%
4-Aminosalicylic Acid
100%
Mesalazine
100%
Chemoprophylaxis
75%
Peroxisome Proliferator Activated Receptor Gamma
50%
Drug Megadose
25%
Colorectal Carcinoma
25%
Anti-Inflammatory Drug
25%
Ulcerative Colitis
25%
Acetylsalicylic Acid
25%
Drug Dose Regimen
25%
Maintenance Therapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
100%
Aminosalicylic Acid
100%
Peroxisome Proliferator Activated Receptor Gamma
28%
Remission
14%
Acetylsalicylic Acid
14%
Ulcerative Colitis
14%
Colorectal Carcinoma
14%
Chemopreventive Agents
14%
Antiinflammatory Agent
14%